Quadrant Capital Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-45
| Closed | -$5K | – | 2687 |
|
|
2021
Q4 | $5K | Hold |
45
| – | – | ﹤0.01% | 1902 |
|
|
2021
Q3 | $9K | Hold |
45
| – | – | ﹤0.01% | 1660 |
|
|
2021
Q2 | $8K | Hold |
45
| – | – | ﹤0.01% | 1685 |
|
|
2021
Q1 | $9K | Hold |
45
| – | – | ﹤0.01% | 1565 |
|
|
2020
Q4 | $9K | Hold |
45
| – | – | ﹤0.01% | 1448 |
|
|
2020
Q3 | $8K | Hold |
45
| – | – | ﹤0.01% | 1340 |
|
|
2020
Q2 | $11K | Buy |
+45
| New | +$11K | ﹤0.01% | 1297 |
|